Figure 2 | Scientific Reports

Figure 2

From: Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema

Figure 2

Change in visual acuity for all patients in the FAS with a BCVA assessment at baseline and Month 24, stratified according to treatment cohort. Values above each bar indicate the mean (± standard deviation) change in BCVA letter score from baseline to Month 24. BCVA, best-corrected visual acuity; ETDRS, Early Treatment Diabetic Retinopathy Study; FAS, full analysis set. ***p < 0.001 and **p < 0.01 for mean change at Month 24 versus baseline (Student t-test).

Back to article page